Medications

Popular diabetes drugs may reduce the risk of dementia

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet published in the journal eClinicalMedicine.

Oncology & Cancer

FDA approves augtyro for NTRK-positive advanced solid tumors

The U.S. Food and Drug Administration has approved Augtyro (repotrectinib), a next-generation tyrosine kinase inhibitor (TKI), for the treatment of patients with neurotrophic tyrosine receptor kinase (NTRK)-positive locally ...

Oncology & Cancer

Deep learning shows promise for soft tissue sarcoma management

Soft tissue sarcomas (STSs) represent a diverse group of tumors that pose significant diagnostic and therapeutic challenges. In a recent review published in the journal Meta-Radiology, a team of researchers from The Second ...

page 14 from 40